Results 71 to 80 of about 6,163 (197)
Non-invasive perilymphatic pressure measurement in patients with Meniere's disease [PDF]
, 1996 The MMS-10 Tympanic Displacement Analyser is a new device to measure the perilymphatic pressure in humans. This instrument was used in 25 patients with Meniere's disease (28 affected ears) and a group of 50 young normal hearing subjects.
Wit, H P +6 more
core +1 more source
Evoked otoacoustic emissions in patients with Meniere's disease [PDF]
, 2002 Hypothesis: This study investigated whether otoacoustic emissions (OAEs) in patients with Meniere's disease show abnormal properties. Background: Patients with Meniere's disease experience vertigo. tinnitus, and hearing loss. OAEs are sounds generated in
de Kleine, E +5 more
core +2 more sources
Labyrinthine Abnormalities on MRI in Untreated Otosclerosis: Prevalence and Clinical Relevance
The Laryngoscope, Volume 136, Issue 8, Page 3559-3568, August 2026.In untreated otosclerosis with labyrinthine symptoms, delayed 3D FLAIR MRI rarely demonstrates endolymphatic hydrops but frequently reveals blood–labyrinth barrier (BLB) disruption. BLB enhancement is spatially associated with cochlear endosteal and round window involvement and increases with the severity of the hearing loss phenotype.
Héléna Pencroffi +7 more
wiley +1 more source
Menière's Disease and Disorders of the Carbohydrate Metabolism Involving the Inner Ear
International Archives of Otorhinolaryngology, 2019 Introduction Menière’s disease was described in 1861, but there are still uncertainties regarding its pathophysiology and treatment. Endolymphatic hydrops is recognized as a fundamental pathological characteristic of the disease, as a result of an ...
Pedro L. Mangabeira Albernaz
doaj +1 more source
Advanced Science, Volume 13, Issue 39, 13 July 2026.This study identifies the HDAC6/GATA4/HtrA1 axis as a critical driver of cellular senescence in the inner ear. GATA4 nuclear translocation, facilitated by HDAC6 downregulation, transcriptionally activates HtrA1, promoting hair cell senescence, SASP, and audio‐vestibular dysfunction in models of Ménière's disease and age‐related audio‐vestibular ...
Na Zhang +16 more
wiley +1 more source
Hippocampal volume measurement in patients with Meniere's disease: a pilot study [PDF]
, 2007 Conclusion. No signs of chronic stress as in hippocampal atrophy were present in patients with Meniere's disease. Objective. To evaluate the effect of chronic stress (allostatic load) by measuring hippocampal volume in patients with Meniere's disease ...
Albers, Frans W. J. +5 more
core +1 more source
Symptom Overlap and Neurobiological Similarities Between Posttraumatic Stress Disorder and Tinnitus
Human Brain Mapping, Volume 47, Issue 10, July 2026.Results from this study showed patterns in which those with PTSD and tinnitus demonstrated decreased functional connectivity between certain brain regions compared to those with only tinnitus and healthy controls. ABSTRACT Many symptoms of posttraumatic stress disorder (PTSD) overlap with the psychological sequelae of tinnitus, including sleep ...
John C. Moring +14 more
wiley +1 more source
Stress and symptoms of Meniere's disease: A time-series analysis [PDF]
, 1997 Meniere's disease is an inner ear disease in which the symptom cluster of hearing loss, tinnitus, and dizziness is found along with attacks of vertigo and nausea.
Andersson, Gerhard, +2 more
core
The change of hippocampal volume and its relevance with inner ear function in Meniere's disease patients [PDF]
, 2017 OBJECTIVES: To reveal the relationship between the disease progression and the hippocampal volume in Meniere's disease, which may indirectly reflect the degree of patients' chronic exposure to stress. METHODS: Retrospective review of medical records and
김진아, 김성헌
core +1 more source
CGRP‐Targeted Therapy in Vestibular Migraine—How Strong Is the Evidence?
European Journal of Neurology, Volume 33, Issue 7, July 2026.ABSTRACT Background Medications for migraine prevention targeting the calcitonin gene‐related peptide (CGRP) pathway have substantially reduced symptom burden in many patients that have failed previous treatment strategies. In contrast, data on treatment response to monoclonal antibodies (mAbs) or small molecule receptor antagonists (gepants) in ...
Alexander Andrea Tarnutzer +2 more
wiley +1 more source